Business Standard

Serbia sees production of Sputnik V by the year-end, says President

A group of Russian experts is expected to visit Serbia next week for talks about local production of the Sputnik V vaccine by the end of the year

Covid-19 coronavirus
Premium

Under the state vaccination programme, Serbians can currently choose between shots from Pfizer Inc-BioNTech, China's Sinopharm or Russia's Sputnik V

Reuters
Serbia will invest as much as necessary to start domestic production of Russia's Sputnik V by the end of the year, President Aleksandar Vucic told Reuters on Friday.
 
A group of Russian experts is expected to visit Serbia next week for talks about local production of the Sputnik V vaccine by the end of the year.
 
Vucic said he and Russian President Vladimir Putin had reached an initial agreement about the launch of the production procedure which he described as "complicated and difficult." With over 530,000 people, or around 7.5% of its population, inoculated against COVID-19, Serbia globally holds the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in